ScenariosSummary of Potential Issues

• New formulations:

  • May not meet BE criteria, particularly for Cmax

• Change in dosing regimen:

  • Target AUC or Cmin, other exposure measures will be different
  • Different shape of concentration vs. time curve

• Drug interactions: typical

  • Target AUC or Cmin; do not have flexibility to match all exposure measures

Previous slide

Next slide

Back to first slide

View graphic version